Finding Capital Investments
In today’s challenging fundraising climate, identifying the right investors and securing venture capital is more crucial than ever for biotech startups to remain competitive in the life sciences industry. Our panel of expert will provide valuable insights into the current market for dilutive capital investment types, emerging therapeutic areas, and what investors seek in startup companies.
We invite you to join us on May 31st, 3pm-5pm at The Wistar Institute (3601 Spruce St.) to gain an understanding of the current state of dilutive capital investments and meet new and established faces in our region’s venture capital scene.
Moderator:
Michele Washko
President & CEO
Life Sciences Greenhouse Investments
Panelists:
Lorenzo Pellegrini, PhD
Managing Partner
Hatch Biofund
Frederick Jones, MD
Partner
BioAdvance
Kathie Jordan, PhD
Managing Director
Healthcare Investment Group
Ben Franklin Technology Partners of Southeastern Pennsylvania
